PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Europe down after Easter holiday weekend

Tue, 02nd Apr 2024 16:57

(Alliance News) - The FTSE 100 took a hit on Tuesday, after a boost from London's miners and oil firms were not enough to lift the index.

The FTSE 100 index closed down 17.53 points, 0.2%, at 7,935.09. The FTSE 250 ended down 170.84 points, 0.9%, at 19,713.89, and the AIM All-Share closed down 0.86 of a point, 0.1%, at 742.40.

The Cboe UK 100 ended down 0.3% at 793.40, the Cboe UK 250 closed down 1.1% at 17,147.56, and the Cboe Small Companies ended down slightly at 14,553.13.

In European equities on Tuesday, the CAC 40 in Paris ended down 0.9%, while the DAX 40 in Frankfurt ended down 1.1%.

After a long Easter weekend, markets reopened on Tuesday to a busy day on the corporate and economic calendar.

Data from S&P Global on Tuesday showed the UK manufacturing sector crossing the no-change mark into growth territory in March.

The seasonally adjusted S&P Global UK manufacturing purchasing managers' index reading was 50.3 points in March, up from 47.5 in February and beating the earlier flash estimate of 49.9.

The latest figure was above the 50-point no-change mark, meaning the UK manufacturing sector returned to growth territory.

PMI data from the eurozone was more disheartening, however.

The latest Hamburg Commercial Bank manufacturing PMI fell to 46.1 points in March, from 46.5 in February. The latest reading was a three-month low, but topped the flash estimate of 45.7 points.

Hamburg Commercial Bank analyst Cyrus de la Rubia commented: "It's a bit disheartening: over the last eight months, the manufacturing industry has been gradually climbing the output PMI ladder, but it still finds itself on the basement staircase."

More positively for the eurozone, Germany saw inflation ease in March.

The consumer price index rose by 2.2% annually in March, ebbing from a 2.5% rise in February. This came in line with FXStreet-cited market consensus and is the lowest value since April 2021.

Analysts at ING said: "despite the early timing of Easter this year, prices for leisure, packaged holidays and hotels and restaurants rose less than expected month-on-month than expected. The Easter bunny effect, ie the base effect stemming from the timing of Easter, was hardly visible this year."

The pound was quoted at USD1.2564 at the London equities close Tuesday, lower compared to USD1.2640 at the close on Thursday. The euro stood at USD1.0771 at the European equities close Tuesday, down against USD1.0803 at the same time on Thursday. Against the yen, the dollar was trading at JPY151.60, up compared to JPY151.29 late Thursday.

In the FTSE 100, miners were among the better large-cap performers. Fresnillo, Anglo American, Glencore, and Rio Tinto traded 7.6%, 4.6%, 3.0%, and 2.0% higher respectively.

The miners got a boost from the latest set of PMI data from China. Monthly factory activity in China grew for the first time in half a year, official figures showed, in a positive sign for policymakers seeking to revive the world's second-largest economy.

The PMI came in at 50.8 points in March, according to the National Bureau of Statistics, up from 49.1 in February. The last expansion in China's monthly PMI was in September, with factory activity consistently negative since then, according to NBS data.

The trend of improvement was confirmed by the Caixin manufacturing PMI, which edged up to 51.1 from 50.9.

Oil firms also did well on Tuesday, on the back of higher oil prices. Shell and BP rose 3.2% and 2.5% respectively.

Brent oil was quoted at USD88.11 a barrel at the London equities close Tuesday, up from USD86.56 late Thursday.

"The ongoing rise in oil prices amid a tighter supply outlook is a worry for corporates and consumers as it is a major inflationary force," said Russ Mould, investment director at AJ Bell.

On the other hand, housebuilders were in the red. Taylor Wimpey, Persimmon, and Barratt Developments lost 3.1%, 3.5%, and 0.1%, respectively.

They were hit by a fall in house prices in the most recent month.

The Nationwide house price index showed a 0.2% decline in seasonally adjusted UK house prices in March from February, compared to a 0.7% rise in February from January. According to FXStreet, market consensus expected the house price index to rise 0.3% last month.

Annually, the house price index rose 1.6% in March compared to a year ago, improving from an annual rise of 1.2% in February, but undershooting FXStreet-cited expectations of a 2.4% rise.

Elsewhere in London, on AIM, Orcadian Energy surged 86%.

The oil and gas development company said it has completed the farm-out of 81% interest in Licence P2244, which contains the Pilot field, to Ping Petroleum UK PLC. Ping is focused on shallow water offshore production, and has a significant acreage holding to the East of Pilot.

On the other hand, Redx Pharma plummeted 65%, after it said it intends to cancel its shares from trading on AIM in London.

The clinical-stage biotechnology company said the board unanimously concluded that it is in the best interests of the company to re-register as a private limited company, as it is "still liquidity constrained" on AIM.

Chair Jane Griffith said: "The board believes that as a private company we can access a broader universe of specialty investors and, accordingly, a larger quantum of future funding required to execute our strategy and maximise our value in the interests of all our shareholders."

Stocks in New York were lower at the London equities close, with the DJIA down 1.1%, the S&P 500 index down 0.9%, and the Nasdaq Composite down 1.2%.

Gold was quoted at USD2,266.55 an ounce at the London equities close Tuesday, up against USD2,221.01 at the close on Thursday.

In Wednesday's UK corporate calendar, there are full year results from Hilton Food, Impax Environmental Markets, and Pantheon Infrastructure.

The economic calendar for Wednesday has unemployment and CPI data from the eurozone out at 1000 BST.

There are also a number of Federal Reserve members who are scheduled to speak, including Fed Chair Jerome Powell, Vice Chair Michale Barr, Governor Michelle Bowman, and Governor Adriana Kugler.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
24 Feb 2016 09:44

Redx Pharma Makes Progress On Gonorrhoea Treatment And Other Drugs

Read more
20 Jan 2016 10:00

Redx Pharma Continues Pipeline Progressing In Maiden Results

Read more
13 Jan 2016 16:00

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Jan 2016 08:35

New Redx director brings scientific, commercial expertise

(ShareCast News) - Redx announced the appointment of a non-executive director on Monday, with Dr Bernhard Kirschbaum joining the firm's board immediately. The AIM-listed self-described drug discovery and development company said Dr Kirschbaum was bringing with him more than 25 years experience in ph

Read more
3 Dec 2015 07:54

Redx Pharma Identifies New Cancer Drug Development Candidate

Read more
6 Nov 2015 09:42

DIRECTOR DEALINGS: Redx Pharma Chairman, Non-Executives Buy Shares

Read more
1 Oct 2015 07:36

Redx Pharma Says It Made "Good Progress" In Second Half

Read more
3 Sep 2015 08:00

Redx Pharma And Horizon Discovery Collaborating On Cancer Research

Read more
22 Jun 2015 14:17

Redx Pharma enjoys good progress during first-half

Two months after its admission to AIM, Redx Pharma said its first-half results were in line with expectations thanks to progress on potential MRSA drugs. Losses before tax rose 60.5% to £3.26m due to a decrease in grant funding and operating expenses increased 5% to £5.48m. The drug discovery and d

Read more
22 Jun 2015 08:35

Redx Pharma Positive For Full Year, Loss Widens In Maiden Interims

Read more
2 Jun 2015 11:13

Redx Pharma cheers with progress on potential MRSA drug

Redx shares jumped on the news it has reached the pre-clinical development stage with a new anti-infective compound designed to tackle MRSA, the bacteria that causes potentially lethal infections in humans. The pharmaceutical firm said the progress marked a "significant milestone" for its commercial

Read more
2 Jun 2015 07:00

Redx Pharma Progresses To Pre-Clinical Stage With MRSA Treatment

Read more
26 May 2015 07:43

Redx Pharma Identifies Second Drug Development Candidate

Read more
14 May 2015 09:41

Redx Pharma To Launch New Immunology Subsidiary

Read more
14 May 2015 08:55

Redx Pharma Says Third Paper On Antimicrobial Resistance Published

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.